Advanced Search

A practical guide to amplicon and metagenomic analysis of microbiome data
Yong-Xin Liu, Yuan Qin, Tong Chen, Meiping Lu, Xubo Qian, Xiaoxuan Guo, Yang Bai
2021, 12(5): 315-330. DOI: 10.1007/s13238-020-00724-8
[Abstract] [PDF]
The microbiome in inflammatory bowel diseases: from pathogenesis to therapy
Sheng Liu, Wenjing Zhao, Ping Lan, Xiangyu Mou
2021, 12(5): 331-345. DOI: 10.1007/s13238-020-00745-3
[Abstract] [PDF]
Gut microbes in cardiovascular diseases and their potential therapeutic applications
Ling Jin, Xiaoming Shi, Jing Yang, Yangyu Zhao, Lixiang Xue, Li Xu, Jun Cai
2021, 12(5): 346-359. DOI: 10.1007/s13238-020-00785-9
[Abstract] [PDF]
The role of the gut microbiome and its metabolites in metabolic diseases
Jiayu Wu, Kai Wang, Xuemei Wang, Yanli Pang, Changtao Jiang
2021, 12(5): 360-373. DOI: 10.1007/s13238-020-00814-7
[Abstract] [PDF]
Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
Wei Jia, Cynthia Rajani, Hongxi Xu, Xiaojiao Zheng
2021, 12(5): 374-393. DOI: 10.1007/s13238-020-00748-0
[Abstract] [PDF]
Role of gut microbiota in identification of novel TCM-derived active metabolites
Tzu-Lung Lin, Chia-Chen Lu, Wei-Fan Lai, Ting-Shu Wu, Jang-Jih Lu, Young-Mao Chen, Chi-Meng Tzeng, Hong-Tao Liu, Hong Wei, Hsin-Chih Lai
2021, 12(5): 394-410. DOI: 10.1007/s13238-020-00784-w
[Abstract] [PDF]
Targeting the alternative bile acid synthetic pathway for metabolic diseases
Wei Jia, Meilin Wei, Cynthia Rajani, Xiaojiao Zheng
2021, 12(5): 411-425. DOI: 10.1007/s13238-020-00804-9
[Abstract] [PDF]
Unexpected guests in the tumor microenvironment: microbiome in cancer
Abigail Wong-Rolle, Haohan Karen Wei, Chen Zhao, Chengcheng Jin
2021, 12(5): 426-435. DOI: 10.1007/s13238-020-00813-8
[Abstract] [PDF]